|
|
|
|
| LEADER |
02835nmm a2200277 u 4500 |
| 001 |
EB001843879 |
| 003 |
EBX01000000000000001007868 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
180802 ||| eng |
| 020 |
|
|
|a 9789811086069
|
| 100 |
1 |
|
|a Moriya, Takuya
|e [editor]
|
| 245 |
0 |
0 |
|a Pathology of Female Cancers
|h Elektronische Ressource
|b Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas
|c edited by Takuya Moriya
|
| 250 |
|
|
|a 1st ed. 2018
|
| 260 |
|
|
|a Singapore
|b Springer Nature Singapore
|c 2018, 2018
|
| 300 |
|
|
|a VII, 91 p. 73 illus. in color
|b online resource
|
| 505 |
0 |
|
|a New strategies for diagnosis of squamous intraepithelial neoplasia of the uterine cervix -- Adenocarcinoma and its precursor of the uterine cervix: current concept -- Heterogeneity of the precursor lesions of endometrial carcinoma, according to the histologic subtype -- Current concept of precancerous and early stage of serous ovarian carcinoma -- Ovarian carcinomas associated with endometriosis -- Problems with the histological diagnosis of epithelial borderline tumors of the ovary -- Development of breast carcinoma in relation to the intrinsic subtype -- Risk assessments of breast cancer occurrence, by morphological and molecular approach
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Oncology
|
| 653 |
|
|
|a Pathology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-10-8606-9?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.07
|
| 520 |
|
|
|a This book focuses on precursor lesions, borderline lesions, and early carcinomas of female-specific organs from the standpoint of pathology. In 2012, the latest WHO Classification of Tumours of the Breast, 4th ed., was published and subsequently, in 2014, the WHO Classification of Tumours of Female Reproductive Organs, 4th ed., was published. In these fourth editions, several new concepts are addressed that were not described in the previous editions, and many of them are related to the awareness of the specific pathogenesis of tumors in female patients. Although some of these issues are still controversial, several paradigm shifts should be understood by medical scientists. Thus researchers, diagnostic pathologists, and clinicians must share current information about what is taking place in the field and what the next issue to resolve is. This volume greatly broadens the reader’s understanding of the new concepts and paradigm shifts, as it includes informationon how to diagnose and make differential diagnoses on a practical basis and also provides a thorough explanation of the molecular–clinicopathologic basis of the new concepts. The book thus benefits gynecologists, breast surgeons, gynecologic–medical oncologists, and cytotechnologists
|